GlassScriptPhysician profile
Gerald Bernard Taylor
NPI 1184649261
$7,100.83
in general payments reported to CMS, 2019-2025
16 companies · $861 in 2025
The $861 reported for 2025 was more than what a typical Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) provider received nationally (typical 2025 total: $413).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $658 · 2020: $203 · 2021: $1,138 · 2022: $914 · 2023: $2,339 · 2024: $988 · 2025: $861.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,188.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,187.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coloplast Corp | $2,990.21 | 2019-2025 | Altis, Restorelle |
| Axonics, INC. | $2,241.94 | 2021-2024 | Axonics, Bulkamid |
| Boston Scientific Corporation | $762.68 | 2019-2025 | Advantage System, Axonics, Upsylon |
| Intuitive Surgical, INC. | $284.32 | 2023-2025 | |
| Medtronic USA, INC. | $279.88 | 2019-2020 | |
| Sumitomo Pharma America, INC. | $160.85 | 2023-2024 | Gemtesa |
| Medtronic, INC. | $121.45 | 2021-2024 | Interstim |
| Caldera Medical, INC | $89.38 | 2023 | Desara |
| Karl Storz Endoscopy-America | $55.64 | 2022 | |
| Abbvie INC. | $26.05 | 2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $23.38 | 2025 | Xifaxan |
| Janssen Pharmaceuticals, INC | $22.40 | 2019 | |
| Ardelyx, INC. | $18.50 | 2025 | Ibsrela |
| Allergan, INC. | $12.77 | 2019 | |
| Aspira Women'S Health INC | $11.38 | 2023 | Ova1 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gerald Taylor listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.